Best GLP-1 Medications for Weight Loss
A comprehensive comparison of every GLP-1 option available in 2026
Zepbound (tirzepatide)
Dual GIP/GLP-1 mechanism produced the highest weight loss in any FDA-approved medication trial.
Advantages
- Highest weight loss in clinical trials
- Dual-hormone mechanism
- Lower nausea than semaglutide
Considerations
- Limited insurance coverage for weight loss
- Newer, less long-term data
- No oral form
Wegovy (semaglutide 2.4 mg)
Proven cardiovascular benefit (SELECT trial). Broadest insurance coverage among weight loss GLP-1s.
Advantages
- Proven heart health benefits
- Broadest insurance coverage
- Extensive safety data
Considerations
- Less weight loss than Zepbound
- Higher list price
- GI side effects common during titration
Mounjaro (tirzepatide)
Same drug as Zepbound. Better insurance coverage when prescribed for diabetes.
Advantages
- Same efficacy as Zepbound
- Better diabetes insurance coverage
- 6 dose levels
Considerations
- Not FDA-approved for weight loss
- Off-label use may not be covered
- Newer drug
Ozempic (semaglutide 2 mg)
Most widely prescribed GLP-1 in the US. Strong insurance coverage for diabetes.
Advantages
- 7+ year safety record
- Strongest insurance coverage
- Manufacturer savings available
Considerations
- Lower max dose than Wegovy
- Not FDA-approved for weight loss
- Less effective than tirzepatide
Saxenda (liraglutide)
First FDA-approved GLP-1 for weight loss. Daily injection (not weekly).
Advantages
- Longest safety track record
- FDA-approved for weight loss
- Approved for teens 12+
Considerations
- Daily injection required
- Less effective than newer options
- Higher cost relative to efficacy
Compounded Semaglutide
Significantly cheaper but quality depends entirely on the pharmacy. FDA has increased enforcement in 2026.
Advantages
- Much lower cost
- No insurance needed
- Widely available via telehealth
Considerations
- Not FDA-approved
- Quality varies by pharmacy
- FDA enforcement increasing
- No standardized trials
The Bottom Line
For maximum weight loss, Zepbound (tirzepatide) leads the field with 20-22% average body weight reduction. For the best-established option with cardiovascular benefits, Wegovy (semaglutide) is the standard. If cost is the primary concern, compounded semaglutide offers savings but with quality trade-offs. Always work with your healthcare provider to choose the right medication for your specific situation.
Frequently Asked Questions
Zepbound (tirzepatide 15 mg) showed the highest average weight loss in clinical trials at 22.5% of body weight over 72 weeks. Wegovy (semaglutide 2.4 mg) is second at approximately 15-17%.
Compounded semaglutide ($200-$500/month) is the most affordable, though it is not FDA-approved. Among brand-name options, manufacturer savings programs and insurance coverage can reduce costs to $0-$25/month for qualifying patients.
Yes, all GLP-1 medications — including compounded versions — require a prescription from a licensed healthcare provider. This can be obtained through in-person visits or telehealth consultations.
Clinical trials have studied use up to 2+ years with continued benefit. Most providers recommend long-term use for sustained weight management, as weight regain is common after stopping. Your doctor will monitor your progress and adjust treatment as needed.
Ready to start treatment?
Search our directory of 2,770 GLP-1 clinics across all 50 states. Filter by medication, insurance, and telehealth availability.
Medical Disclaimer: This guide is for informational purposes only and is not medical advice. All clinical data is sourced from FDA prescribing information and published peer-reviewed trials. Individual results vary. Always consult a qualified healthcare provider before starting, stopping, or switching any medication.